Malignant melanoma arises by malignant transformation of the
normal melanocytes. Distribution of malignant melanoma includes cutaneous
(91.2%), ocular (5.3%), mucosal (1.3%), and unknown primary site (2.2%).
Because of rarity and clinical challenges arising from different anatomic
location, our understanding for the optimal management of mucosal melanoma
remains limited. Malignant
melanoma can arise from the mucosal epithelium of respiratory, alimentary,
and genitourinary tracts, all of which contain melanocytes. The most common
sites for primary mucosal melanoma include head and neck followed by anorectal,
and vulvovaginal regions (55, 24, and 18%, respectively). Rarer sites are
urinary tract, gallbladder, and small intestine.
Although melanocytes share same embryologic origin, mucosal
melanomas behave more aggressively and have many different characteristics
compared to cutaneous melanomas. Mucosal melanomas are multifocal in 20% cases,
while cutaneous melanomas are multifocal in 5%. 40% of mucosal melanomas are
amelanotic, while <10% of cutaneous melanomas. In the following section we
described this uncommonly presented entity. 5 year survival for mucosal
melanoma is 25%, while that for cutaneous melanoma it is 80.8%.
Etiopathogenesis
Mucosal melanoma arises in non-sun exposed parts of the body
and risk factors are not properly defined. Incidence increases with age and
> 65% of patients are older than 60 years . The difference between white and
black population is less pronounced compared to cutaneous melanoma and mucosal melanomas
are approximately twice higher among whites compared to blacks. The higher
incidence in females compared to males is because of the predominance of
genital tract melanomas in females, which account for 56.5% of mucosal
melanomas among them . There is no difference in rates between genders for
extragenital mucosal melanomas.
No comments:
Post a Comment